Jhaveri K, Drago JZ, Shah PD, Wang R, et al. A Phase I study of alpelisib in combination with trastuzumab and LJM716 in patients with PIK3CA-mutated HER2-positive metastatic breast cancer. Clin Cancer Res 2021 May 4. pii: 1078-0432.CCR-21-0047.
PMID: 33947692